Welcome to LookChem.com Sign In|Join Free

CAS

  • or

124351-86-6

Post Buying Request

124351-86-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

124351-86-6 Usage

Description

[(Cyclooctylamino)methanediyl]bis(phosphonic acid) is an organophosphorus compound characterized by the presence of two phosphonic acid groups connected to a cyclooctylamine moiety. [(cyclooctylamino)methanediyl]bis(phosphonic acid) is recognized for its high stability and effectiveness in binding with metal ions, which contributes to its widespread use in various industrial applications.

Uses

Used in Water Treatment:
[(Cyclooctylamino)methanediyl]bis(phosphonic acid) is used as a chelating agent for the purpose of sequestering metal ions, which helps in preventing scale formation, corrosion, and fouling in water treatment systems.
Used in Metal Cleaning:
In the metal cleaning industry, [(cyclooctylamino)methanediyl]bis(phosphonic acid) is utilized as a corrosion inhibitor. Its ability to bind metal ions aids in protecting metal surfaces from corrosion during the cleaning process.
Used in Oil Drilling:
[(cyclooctylamino)methanediyl]bis(phosphonic acid) is also employed in the oil drilling sector as a chelating agent. It helps in the removal of metal ions and prevents scaling, which can cause blockages and reduce the efficiency of oil extraction operations.
Used in Pharmaceutical Production:
[(Cyclooctylamino)methanediyl]bis(phosphonic acid) is used as a chelating agent in the production of pharmaceuticals. Its complexing properties are beneficial for the synthesis of various drug compounds.
Used in Agricultural Chemicals:
In the agricultural chemicals industry, [(cyclooctylamino)methanediyl]bis(phosphonic acid) is utilized for its chelating capabilities, which are essential in the formulation of certain agrochemical products.
Environmental and Health Impact:
There is ongoing research focused on understanding the environmental and health impact of [(cyclooctylamino)methanediyl]bis(phosphonic acid), particularly concerning its persistence in the environment and potential toxicity. This is crucial for assessing the long-term sustainability and safety of using this compound in various applications.

Check Digit Verification of cas no

The CAS Registry Mumber 124351-86-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,4,3,5 and 1 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 124351-86:
(8*1)+(7*2)+(6*4)+(5*3)+(4*5)+(3*1)+(2*8)+(1*6)=106
106 % 10 = 6
So 124351-86-6 is a valid CAS Registry Number.

124351-86-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name Cyclooctylaminomethylen-1,1-bisphosphonate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:124351-86-6 SDS

124351-86-6Upstream product

124351-86-6Downstream Products

124351-86-6Relevant articles and documents

Effects of Bisphosphonates on the Growth of Entamoeba histolytica and Plasmodium Species in Vitro and in Vivo

Ghosh, Subhash,Chan, Julian M. W.,Lea, Christopher R.,Meints, Gary A.,Lewis, Jared C.,Tovian, Zev S.,Flessner, Ryan M.,Loftus, Timothy C.,Bruchhaus, Iris,Kendrick, Howard,Croft, Simon L.,Kemp, Robert G.,Kobayashi, Seike,Nozaki, Tomoyoshi,Oldfield, Eric

, p. 175 - 187 (2007/10/03)

The effects of a series of 102 bisphosphonates on the inhibition of growth of Entamoeba histolytica and Plasmodium falciparum in vitro have been determined, and selected compounds were further investigated for their in vivo activity. Forty-seven compounds tested were active (IC50 50 ~ 4-9 μM) were nitrogen-containing bisphosphonates with relatively large aromatic side chains. Simple n-alkyl-1-hydroxy-1,1-bisphosphonates, known inhibitors of the enzyme farnesylpyrophosphate (FPP) synthase, were also active, with optimal activity being found with C9-C10 side chains. However, numerous other nitrogen-containing bisphosphonates known to be potent FPP synthase inhibitors, such as risedronate or pamidronate, had little or no activity. Several pyridine-derived bisphosphonates were quite active (IC50 ~ 10-20 μM), and this activity was shown to correlate with the basicity of the aromatic group, with activity decreasing with increasing pKa values. The activities of all compounds were tested versus a human nasopharyngeal carcinoma (KB) cell line to enable an estimate of the therapeutic index (TI). Five bisphosphonates were selected and then screened for their ability to delay the development of amebic liver abscess formation in an E. histolytica infected hamster model. Two compounds were found to decrease liver abscess formation at 10 mg/kg ip with little or no effect on normal liver mass. With P. falciparum, 35 compounds had IC50 values 50 values around 1 μM. Five compounds were again selected for in vivo investigation in a Plasmodium berghei ANKA BALB/c mouse suppressive test. The most active compound, a C9 n-alkyl side chain containing bisphosphonate, caused an 80% reduction in parasitemia with no overt toxicity. Taken together, these results show that bisphosphonates appear to be useful lead compounds for the development of novel antiamebic and antimalarial drugs.

Studies on novel bone resorption inhibitors. I. Synthesis and pharmacological activities of aminomethylenebisphosphonate derivatives

Takeuchi,Sakamoto,Yoshida,Abe,Isomura

, p. 688 - 693 (2007/10/02)

A series of aminomethylenebisphosphonate derivatives was synthesized and evaluated for their antiresorptive activities using a parathyroid hormone (PTH)-induced hypercalcemia model in rats (PIH model). Among these compounds, (cycloheptylamino)methylenebis(phosphonic acid) (3j) was finally selected for further investigation, proving 10-fold as potent as pamidronate in the PIH model and an immobilization bone atrophy model in rats (DA model). The structure-activity relationships of this series of bisphosphonates are discussed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 124351-86-6